Hyperammonemic Crisis

Advertisement

cGxPJobs Banner

iECURE Reports 74% Reduction in OTC-HOPE Crises

Philadelphia – August 27, 2026 iECURE, Inc. presented updated clinical data from the ongoing OTC-HOPE Phase 1/2 trial of...

By cGxPwire Editor
August 29, 2026

Read More

Advertisement

cGxPJobs

Directory